Olema Pharmaceuticals, Inc.
OLMA
Cena:
$ 13.68
-0.38 (-2.70%)
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FMR LLC | 10.4 mil | 11.94% | 0.00% | 0.01% | 2020-12-31 |
| PARADIGM BIOCAPITAL ADVISORS LP | 8.0 mil | 9.22% | -2.37% | 2.44% | 2023-03-31 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 7.5 mil | 8.59% | -6.24% | 10.05% | 2024-12-31 |
| JANUS HENDERSON GROUP PLC | 7.1 mil | 8.17% | -0.02% | 0.05% | 2023-12-31 |
| BLACKROCK INC. | 4.0 mil | 7.11% | 0.00% | 0.00% | 2020-12-31 |
| BLACKROCK FUNDING, INC. /DE | 3.8 mil | 6.62% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK, INC. | 5.7 mil | 6.50% | 0.00% | 0.00% | 2024-09-30 |
| BVF INC/IL | 5.3 mil | 6.09% | -1.94% | 2.52% | 2020-12-31 |
| SIREN, L.L.C. | 4.8 mil | 5.47% | -0.50% | 1.97% | 2025-12-31 |
| STATE STREET CORP | 3.9 mil | 4.53% | 0.00% | 0.00% | 2021-03-31 |
| VANGUARD GROUP INC | 3.6 mil | 4.15% | 0.00% | 0.00% | 2020-12-31 |
| DEEP TRACK CAPITAL, LP | 3.5 mil | 4.06% | 0.48% | 0.95% | 2023-09-30 |
| LOGOS GLOBAL MANAGEMENT LP | 3.2 mil | 3.69% | -2.46% | 2.39% | 2020-12-31 |
| RA CAPITAL MANAGEMENT, L.P. | 2.6 mil | 2.99% | -0.26% | 0.41% | 2025-12-31 |
| AVORO CAPITAL ADVISORS LLC | 1.7 mil | 2.88% | 0.14% | 0.14% | 2024-12-31 |
| BIOIMPACT CAPITAL LLC | 2.4 mil | 2.78% | -0.14% | 1.76% | 2023-06-30 |
| JENNISON ASSOCIATES LLC | 1.8 mil | 2.09% | 0.00% | 0.02% | 2025-12-31 |
| POLAR CAPITAL HOLDINGS PLC | 1.6 mil | 1.84% | -0.05% | 0.08% | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5 mil | 1.78% | 0.00% | 0.00% | 2020-12-31 |
| GREAT POINT PARTNERS LLC | 0.00 mld | 1.75% | 1.86% | 3.51% | 2024-06-30 |
| WOODLINE PARTNERS LP | 1.5 mil | 1.70% | -0.06% | 0.08% | 2023-06-30 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1.4 mil | 1.56% | -1.41% | 2.05% | 2024-12-31 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 631.06 tis | 1.40% | 0.71% | 0.71% | 2023-12-31 |
| FRANKLIN RESOURCES INC | 1.2 mil | 1.40% | -0.01% | 0.00% | 2023-09-30 |
| MORGAN STANLEY | 1.2 mil | 1.40% | 0.00% | 0.00% | 2020-12-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.2 mil | 1.36% | 0.00% | 0.00% | 2021-03-31 |
| TWO SIGMA INVESTMENTS, LP | 1.2 mil | 1.34% | 0.00% | 0.01% | 2021-09-30 |
| AMERIPRISE FINANCIAL INC | 1.1 mil | 1.34% | 0.00% | 0.00% | 2023-06-30 |
| BRAIDWELL LP | 704.34 tis | 1.27% | 0.26% | 0.26% | 2024-03-31 |
| SAMLYN CAPITAL, LLC | 1.1 mil | 1.25% | 0.43% | 0.43% | 2025-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 1.1 mil | 1.24% | 0.00% | 0.00% | 2022-09-30 |
| GOLDMAN SACHS GROUP INC | 1.0 mil | 1.20% | 0.00% | 0.00% | 2020-12-31 |
| PERCEPTIVE ADVISORS LLC | 539.83 tis | 1.20% | 0.17% | 0.17% | 2023-12-31 |
| BOXER CAPITAL, LLC | 650.00 tis | 1.14% | 0.01% | 0.38% | 2024-06-30 |
| DUQUESNE FAMILY OFFICE LLC | 986.83 tis | 1.13% | 0.44% | 0.44% | 2026-03-31 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 933.54 tis | 1.09% | 1.23% | 1.23% | 2025-09-30 |
| ALTIUM CAPITAL MANAGEMENT LP | 605.00 tis | 1.09% | -1.23% | 2.71% | 2023-06-30 |
| CITADEL ADVISORS LLC | 905.33 tis | 1.04% | 0.00% | 0.00% | 2020-12-31 |
| ALLY BRIDGE GROUP (NY) LLC | 559.04 tis | 1.01% | -1.99% | 3.52% | 2023-12-31 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 855.00 tis | 0.98% | -1.43% | 1.40% | 2025-09-30 |
| GHOST TREE CAPITAL, LLC | 535.00 tis | 0.93% | 0.07% | 1.93% | 2024-03-31 |
| FIRST TURN MANAGEMENT, LLC | 768.66 tis | 0.88% | -0.48% | 1.28% | 2025-12-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 505.40 tis | 0.88% | -0.02% | 0.02% | 2023-06-30 |
| CANDRIAM S.C.A. | 759.51 tis | 0.87% | -0.03% | 0.06% | 2023-12-31 |
| SQUAREPOINT OPS LLC | 738.55 tis | 0.85% | 0.00% | 0.01% | 2023-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 693.18 tis | 0.81% | 0.01% | 0.01% | 2024-09-30 |
| VIVO CAPITAL, LLC | 671.84 tis | 0.77% | -0.25% | 0.84% | 2020-12-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 664.68 tis | 0.76% | 0.00% | 0.00% | 2023-06-30 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 619.87 tis | 0.73% | 0.31% | 0.31% | 2025-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 618.18 tis | 0.72% | 0.00% | 0.00% | 2024-06-30 |
| EVENTIDE ASSET MANAGEMENT, LLC | 569.00 tis | 0.66% | 0.22% | 0.22% | 2025-12-31 |
| NORTHERN TRUST CORP | 569.96 tis | 0.66% | 0.00% | 0.00% | 2020-12-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 365.20 tis | 0.64% | 0.00% | 0.00% | 2022-03-31 |
| IKARIAN CAPITAL, LLC | 549.80 tis | 0.63% | 0.28% | 0.67% | 2025-12-31 |
| STEMPOINT CAPITAL LP | 281.29 tis | 0.63% | 1.05% | 1.05% | 2023-12-31 |
| PIER CAPITAL, LLC | 524.25 tis | 0.61% | 0.30% | 0.80% | 2024-12-31 |
| HOLOCENE ADVISORS, LP | 506.00 tis | 0.59% | 0.03% | 0.03% | 2025-12-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 502.57 tis | 0.59% | 0.00% | 0.01% | 2024-09-30 |
| BANK OF AMERICA CORP /DE/ | 508.71 tis | 0.58% | 0.00% | 0.00% | 2020-12-31 |
| MILLENNIUM MANAGEMENT LLC | 498.49 tis | 0.58% | 0.00% | 0.01% | 2021-12-31 |
| CORMORANT ASSET MANAGEMENT, LP | 500.00 tis | 0.57% | 0.37% | 0.37% | 2026-03-31 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 481.49 tis | 0.55% | -0.14% | 0.24% | 2024-06-30 |
| ALLIANCEBERNSTEIN L.P. | 313.98 tis | 0.55% | 0.00% | 0.00% | 2023-09-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 466.55 tis | 0.54% | 0.00% | 0.00% | 2021-03-31 |
| JUMP FINANCIAL, LLC | 452.97 tis | 0.52% | 0.06% | 0.09% | 2025-12-31 |
| EAM INVESTORS, LLC | 228.14 tis | 0.51% | -0.01% | 0.57% | 2023-06-30 |
| VESTAL POINT CAPITAL, LP | 428.55 tis | 0.49% | -1.22% | 0.18% | 2025-12-31 |
| DEUTSCHE BANK AG\ | 253.87 tis | 0.45% | 0.00% | 0.00% | 2021-03-31 |
| UBS GROUP AG | 385.06 tis | 0.44% | 0.00% | 0.00% | 2022-09-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 372.20 tis | 0.43% | 0.00% | 0.00% | 2025-12-31 |
| MARSHALL WACE, LLP | 360.39 tis | 0.42% | 0.01% | 0.01% | 2021-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 358.31 tis | 0.41% | 0.00% | 0.00% | 2026-03-31 |
| 339.46 tis | 0.39% | 0.02% | 0.02% | 2026-03-31 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 220.26 tis | 0.38% | 0.01% | 0.01% | 2024-12-31 |
| TREXQUANT INVESTMENT LP | 325.17 tis | 0.37% | 0.02% | 0.03% | 2025-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 312.81 tis | 0.36% | 0.01% | 0.01% | 2026-03-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 307.89 tis | 0.36% | 0.00% | 0.01% | 2024-06-30 |
| BNP PARIBAS ARBITRAGE, SNC | 299.62 tis | 0.35% | 0.00% | 0.00% | 2024-12-31 |
| FISHER ASSET MANAGEMENT, LLC | 299.76 tis | 0.34% | 0.00% | 0.00% | 2026-03-31 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 281.69 tis | 0.33% | 0.03% | 0.03% | 2025-12-31 |
| BIRCHVIEW CAPITAL, LP | 269.00 tis | 0.31% | 2.65% | 3.94% | 2025-06-30 |
| JPMORGAN CHASE & CO | 268.47 tis | 0.31% | 0.00% | 0.00% | 2020-12-31 |
| CATALIO CAPITAL MANAGEMENT, LP | 267.06 tis | 0.31% | 1.18% | 1.18% | 2025-12-31 |
| AFFINITY ASSET ADVISORS, LLC | 250.00 tis | 0.29% | 0.07% | 0.21% | 2025-03-31 |
| HIGHVISTA STRATEGIES LLC | 241.49 tis | 0.28% | 0.51% | 1.55% | 2023-06-30 |
| EXOME ASSET MANAGEMENT LLC | 143.40 tis | 0.26% | 1.39% | 1.39% | 2024-03-31 |
| NEWTYN MANAGEMENT, LLC | 140.00 tis | 0.24% | -0.11% | 0.14% | 2022-06-30 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 135.00 tis | 0.24% | 0.18% | 0.18% | 2024-03-31 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 194.45 tis | 0.23% | 0.00% | 0.00% | 2022-09-30 |
| VERITION FUND MANAGEMENT LLC | 122.18 tis | 0.22% | 0.01% | 0.01% | 2024-03-31 |
| SECTORAL ASSET MANAGEMENT INC | 118.48 tis | 0.21% | -0.10% | 0.52% | 2022-09-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 118.43 tis | 0.21% | 0.00% | 0.00% | 2023-06-30 |
| BANK OF NEW YORK MELLON CORP | 169.20 tis | 0.20% | 0.00% | 0.00% | 2021-03-31 |
| HRT FINANCIAL LP | 108.85 tis | 0.19% | 0.01% | 0.01% | 2024-09-30 |
| ACADIAN ASSET MANAGEMENT LLC | 103.18 tis | 0.19% | -0.01% | 0.00% | 2021-12-31 |
| ROYAL BANK OF CANADA | 148.34 tis | 0.17% | 0.00% | 0.00% | 2023-03-31 |
| VR ADVISER, LLC | 77.04 tis | 0.17% | -0.03% | 0.04% | 2023-09-30 |
| ATOM INVESTORS LP | 94.32 tis | 0.17% | -0.01% | 0.13% | 2023-12-31 |
| TWO SIGMA ADVISERS, LP | 144.40 tis | 0.17% | 0.00% | 0.00% | 2021-09-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 93.98 tis | 0.16% | 0.00% | 0.00% | 2023-12-31 |
| JANE STREET GROUP, LLC | 138.55 tis | 0.16% | 0.00% | 0.00% | 2022-12-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 93.67 tis | 0.16% | 0.00% | 0.00% | 2024-06-30 |
| RAFFERTY ASSET MANAGEMENT, LLC | 90.48 tis | 0.16% | 0.00% | 0.00% | 2024-03-31 |
| ALLOSTERY INVESTMENTS LP | 90.00 tis | 0.16% | 0.55% | 0.55% | 2024-12-31 |
| NUVEEN, LLC | 128.22 tis | 0.15% | 0.00% | 0.00% | 2025-03-31 |
| INVESCO LTD. | 124.63 tis | 0.15% | 0.00% | 0.00% | 2023-06-30 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 121.34 tis | 0.14% | 0.01% | 0.02% | 2025-03-31 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 62.50 tis | 0.14% | 0.01% | 0.01% | 2023-12-31 |
| DANA INVESTMENT ADVISORS, INC. | 112.95 tis | 0.13% | 0.00% | 0.02% | 2024-06-30 |
| CINCTIVE CAPITAL MANAGEMENT LP | 56.52 tis | 0.12% | 0.03% | 0.03% | 2024-03-31 |
| BARCLAYS PLC | 104.62 tis | 0.12% | 0.00% | 0.00% | 2022-03-31 |
| SWISS NATIONAL BANK | 66.00 tis | 0.12% | 0.00% | 0.00% | 2023-12-31 |
| LPL FINANCIAL LLC | 96.68 tis | 0.11% | 0.00% | 0.00% | 2025-03-31 |
| CLARIVEST ASSET MANAGEMENT LLC | 63.15 tis | 0.11% | 0.00% | 0.07% | 2023-06-30 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 94.88 tis | 0.11% | 0.02% | 0.04% | 2024-12-31 |
| STATE OF WISCONSIN INVESTMENT BOARD | 61.37 tis | 0.11% | 0.00% | 0.00% | 2023-12-31 |
| DIADEMA PARTNERS LP | 90.50 tis | 0.11% | 0.23% | 0.23% | 2025-09-30 |
| RENAISSANCE TECHNOLOGIES LLC | 90.10 tis | 0.11% | 0.00% | 0.00% | 2021-09-30 |
| CREDIT SUISSE AG/ | 47.45 tis | 0.10% | 0.00% | 0.00% | 2023-12-31 |
| VICTORY CAPITAL MANAGEMENT INC | 88.45 tis | 0.10% | 0.00% | 0.00% | 2023-09-30 |
| WALLEYE CAPITAL LLC | 87.71 tis | 0.10% | 0.00% | 0.00% | 2024-12-31 |
| EP WEALTH ADVISORS, LLC | 46.25 tis | 0.10% | 0.00% | 0.01% | 2021-12-31 |
| RHUMBLINE ADVISERS | 86.03 tis | 0.10% | 0.00% | 0.00% | 2023-06-30 |
| XTX TOPCO LTD | 80.41 tis | 0.09% | 0.01% | 0.01% | 2024-03-31 |
| ENVESTNET ASSET MANAGEMENT INC | 49.22 tis | 0.09% | 0.00% | 0.00% | 2024-06-30 |
| PDT PARTNERS, LLC | 74.30 tis | 0.09% | 0.02% | 0.02% | 2025-03-31 |
| THRIVENT FINANCIAL FOR LUTHERANS | 72.46 tis | 0.08% | 0.00% | 0.00% | 2025-06-30 |
| CITIGROUP INC | 70.33 tis | 0.08% | 0.00% | 0.00% | 2020-12-31 |
| ALPS ADVISORS INC | 43.65 tis | 0.08% | 0.00% | 0.00% | 2023-12-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 58.98 tis | 0.07% | 0.00% | 0.00% | 2024-09-30 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 33.29 tis | 0.06% | 0.00% | 0.00% | 2023-06-30 |
| LEGAL & GENERAL GROUP PLC | 32.17 tis | 0.06% | 0.00% | 0.00% | 2023-06-30 |
| VOYA INVESTMENT MANAGEMENT LLC | 31.47 tis | 0.06% | 0.00% | 0.00% | 2023-06-30 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 31.41 tis | 0.06% | 0.01% | 0.01% | 2024-06-30 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 28.17 tis | 0.05% | 0.00% | 0.00% | 2024-03-31 |
| PITCAIRN CO | 27.01 tis | 0.05% | 0.02% | 0.02% | 2024-06-30 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 23.70 tis | 0.04% | 0.00% | 0.00% | 2023-06-30 |
| D. E. SHAW & CO., INC. | 21.06 tis | 0.04% | 0.00% | 0.00% | 2023-12-31 |
| PROFUND ADVISORS LLC | 18.91 tis | 0.03% | -0.01% | 0.01% | 2024-03-31 |
| NEW YORK STATE COMMON RETIREMENT FUND | 16.99 tis | 0.03% | 0.00% | 0.00% | 2023-06-30 |
| WELLS FARGO & COMPANY/MN | 16.31 tis | 0.03% | 0.00% | 0.00% | 2020-12-31 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 15.89 tis | 0.03% | 0.00% | 0.00% | 2023-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Raman Prakash | 0 | 0.00 | 29.4 2026 | 0 | ||
| Raman Prakash | director | A-Award | 2911 | 14.59 | 29.4 2026 | 2911 |
| Raman Prakash | director | A-Award | 24150 | 14.59 | 29.4 2026 | 24150 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | S-Sale | 233 | 24.69 | 5.3 2026 | 0 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | S-Sale | 15000 | 23.01 | 5.3 2026 | 0 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | S-Sale | 24767 | 24.25 | 5.3 2026 | 233 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | M-Exempt | 15000 | 4.37 | 5.3 2026 | 15000 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | M-Exempt | 25000 | 4.37 | 5.3 2026 | 25000 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | M-Exempt | 25000 | 4.37 | 5.3 2026 | 410000 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | M-Exempt | 15000 | 4.37 | 5.3 2026 | 435000 |
| Austin Sasha Lu | officer: VP of Finance and Controller | 45000 | 4.37 | 17.2 2026 | 0 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 51000 | 15.25 | 17.2 2026 | 0 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 17500 | 3.49 | 17.2 2026 | 0 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 6500 | 4.87 | 17.2 2026 | 0 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 13000 | 2.44 | 17.2 2026 | 0 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | 0 | 0.00 | 17.2 2026 | 4488 | |
| Austin Sasha Lu | officer: VP of Finance and Controller | A-Award | 11700 | 0.00 | 17.2 2026 | 16188 |
| Austin Sasha Lu | officer: VP of Finance and Controller | A-Award | 29250 | 25.65 | 17.2 2026 | 29250 |
| Bohen Sean | director, officer: PRESIDENT AND CEO | A-Award | 275000 | 25.65 | 4.2 2026 | 275000 |
| Bohen Sean | director, officer: PRESIDENT AND CEO | A-Award | 850000 | 25.65 | 4.2 2026 | 850000 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | A-Award | 56250 | 25.65 | 4.2 2026 | 56250 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | A-Award | 220000 | 25.65 | 4.2 2026 | 220000 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | A-Award | 106250 | 25.65 | 4.2 2026 | 106250 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | A-Award | 250000 | 25.65 | 4.2 2026 | 250000 |
| Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | A-Award | 106250 | 25.65 | 4.2 2026 | 106250 |
| Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | A-Award | 250000 | 25.65 | 4.2 2026 | 250000 |
| Harmon Cyrus | director | S-Sale | 10000 | 26.88 | 21.1 2026 | 727770 |
| Harmon Cyrus | director | S-Sale | 3489 | 29.12 | 16.1 2026 | 737770 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | S-Sale | 100000 | 28.73 | 15.1 2026 | 139727 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | S-Sale | 3822 | 28.01 | 15.1 2026 | 239727 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | M-Exempt | 50000 | 4.87 | 14.1 2026 | 50000 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | M-Exempt | 50000 | 4.87 | 14.1 2026 | 100000 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 10000 | 28.34 | 14.1 2026 | 144846 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 200 | 28.49 | 14.1 2026 | 542761 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 35003 | 28.99 | 14.1 2026 | 542761 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 49800 | 27.60 | 14.1 2026 | 542961 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 14997 | 28.60 | 14.1 2026 | 577764 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | M-Exempt | 50000 | 4.87 | 14.1 2026 | 592761 |
| Bohen Sean | director, officer: President and CEO | G-Gift | 8500 | 0.00 | 30.12 2025 | 237650 |
| Harmon Cyrus | director | S-Sale | 2881 | 28.53 | 29.12 2025 | 741259 |
| Zojwalla Naseem | officer: Chief Medical Officer | S-Sale | 99509 | 27.66 | 23.12 2025 | 4488 |
| Zojwalla Naseem | officer: Chief Medical Officer | S-Sale | 100000 | 28.04 | 23.12 2025 | 53997 |
| Zojwalla Naseem | officer: Chief Medical Officer | S-Sale | 12921 | 28.93 | 23.12 2025 | 103997 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 50000 | 7.02 | 23.12 2025 | 103997 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 42818 | 15.25 | 23.12 2025 | 112182 |
| Zojwalla Naseem | officer: Chief Medical Officer | S-Sale | 57079 | 28.03 | 23.12 2025 | 116918 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 42818 | 15.25 | 23.12 2025 | 146815 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 7182 | 7.02 | 23.12 2025 | 153997 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 40000 | 15.25 | 23.12 2025 | 155000 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 50000 | 7.02 | 23.12 2025 | 156818 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 40000 | 15.25 | 23.12 2025 | 173997 |
| Zojwalla Naseem | officer: Chief Medical Officer | M-Exempt | 7182 | 7.02 | 23.12 2025 | 206818 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | G-Gift | 9000 | 0.00 | 23.12 2025 | 542881 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 6046 | 31.39 | 23.12 2025 | 551881 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 43729 | 30.40 | 23.12 2025 | 557927 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | S-Sale | 1225 | 28.08 | 23.12 2025 | 601656 |
| CLARK IAN T | director | M-Exempt | 21520 | 3.61 | 23.12 2025 | 0 |
| CLARK IAN T | director | S-Sale | 41840 | 30.48 | 23.12 2025 | 0 |
| CLARK IAN T | director | M-Exempt | 209690 | 4.41 | 23.12 2025 | 0 |
| CLARK IAN T | director | M-Exempt | 21520 | 7.84 | 23.12 2025 | 0 |
| CLARK IAN T | director | M-Exempt | 12070 | 4.08 | 23.12 2025 | 12080 |
| CLARK IAN T | director | S-Sale | 193056 | 29.71 | 23.12 2025 | 41840 |
| CLARK IAN T | director | M-Exempt | 209690 | 4.41 | 23.12 2025 | 209690 |
| CLARK IAN T | director | M-Exempt | 21520 | 3.61 | 23.12 2025 | 231210 |
| CLARK IAN T | director | S-Sale | 29904 | 28.83 | 23.12 2025 | 234896 |
| CLARK IAN T | director | M-Exempt | 21520 | 7.84 | 23.12 2025 | 252730 |
| CLARK IAN T | director | M-Exempt | 12070 | 4.08 | 23.12 2025 | 264800 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | G-Gift | 75000 | 0.00 | 9.12 2025 | 243549 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | G-Gift | 225000 | 0.00 | 1.12 2025 | 318549 |
| RAPPAPORT ANDREW | director | G-Gift | 35868 | 0.00 | 25.11 2025 | 0 |
| RAPPAPORT ANDREW | director | M-Exempt | 35868 | 0.39 | 25.11 2025 | 0 |
| RAPPAPORT ANDREW | director | M-Exempt | 35868 | 0.39 | 25.11 2025 | 35868 |
| Harmon Cyrus | director | S-Sale | 3086 | 8.32 | 18.9 2025 | 117028 |
| Harmon Cyrus | director | S-Sale | 1914 | 8.08 | 18.9 2025 | 120114 |
| Harmon Cyrus | director | S-Sale | 10000 | 8.33 | 18.9 2025 | 744140 |
| Harmon Cyrus | director | S-Sale | 10000 | 8.04 | 18.9 2025 | 754140 |
| RAPPAPORT ANDREW | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| BUTITTA CYNTHIA M | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Harmon Cyrus | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Graham G. Walmsley | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Hrustanovic Gorjan | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| CLARK IAN T | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Horning Sandra | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Garland J. Scott | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Larson Yi | director | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | A-Award | 24150 | 4.08 | 13.6 2025 | 24150 |
| Graham G. Walmsley | director: | 0 | 0.00 | 13.5 2025 | 0 | |
| Bohen Sean | director, officer: PRESIDENT AND CEO | A-Award | 650000 | 4.37 | 3.3 2025 | 650000 |
| Kovacs Shane William Charles | officer: CH. OPERATING & FINANCIAL OFF. | A-Award | 320000 | 4.37 | 3.3 2025 | 320000 |
| Mitchell Shawnte | officer: CHIEF LEGAL OFFICER | A-Award | 450000 | 4.37 | 3.3 2025 | 450000 |
| Zojwalla Naseem | officer: CHIEF MEDICAL OFFICER | A-Award | 205000 | 4.37 | 3.3 2025 | 205000 |
| Myles David C. | officer: CH. DISCOV. & NON-CLIN DEV OFF | A-Award | 205000 | 4.37 | 3.3 2025 | 205000 |
| Mitchell Shawnte | 0 | 0.00 | 28.2 2025 | 0 | ||
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | A-Award | 22740 | 0.00 | 14.1 2025 | 336288 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | D-Return | 22740 | 0.00 | 14.1 2025 | 347970 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | D-Return | 161810 | 0.00 | 14.1 2025 | 2003966 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | A-Award | 161810 | 0.00 | 14.1 2025 | 2627590 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | D-Return | 235450 | 0.00 | 14.1 2025 | 2655977 |
| BVF PARTNERS L P/IL | director, other: See Explanation of Responses | A-Award | 235450 | 0.00 | 14.1 2025 | 3291004 |
| Bain Capital Life Sciences Investors, LLC | 10 percent owner | P-Purchase | 300000 | 5.76 | 13.1 2025 | 7800000 |
